Universal CAR-T Cells Targeting AML

Clinical trial NCT05995041 · RECRUITING

Trial details

NCT number: NCT05995041
Sponsor: Shenzhen Geno-Immune Medical Institute
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2026-06-01
Primary completion: 2029-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.